RSS-Feed abonnieren

DOI: 10.1590/0004-282X-ANP-2021-0133
Dialysis headache: characteristics, impact and cerebrovascular evaluation
Cefaleia da diálise: características, impacto e avaliação cerebrovascular
ABSTRACT
Background: Headache is one of the most frequent symptoms that occur during hemodialysis sessions. Despite the high prevalence of dialysis headache, it has been little studied. Objective: To evaluate the characteristics, impact and factors associated with dialysis headache. The behavior of the cerebral vasculature was also compared between patients with and without dialysis headache. Methods: This was a cross-sectional study. Consecutive patients who underwent hemodialysis were assessed through a semi-structured questionnaire, the Headache Impact Test (HIT-6), the Hospital Anxiety and Depression Scale and the Short Form-36 Health Survey (SF-36). Transcranial Doppler ultrasonography was performed in the first and fourth hours of hemodialysis. Results: A total of 100 patients were included; 49 of them had dialysis headache. Women (OR=5.04; 95%CI 1.95-13.04), younger individuals (OR=1.05; 95%CI 1.01-1.08), individuals with higher schooling levels (OR=3.86; 95%CI 1.4-10.7) and individuals who had spent longer times on dialysis programs (OR=0.99; 95%CI 0.98-1) had more dialysis headache (logistic regression). Individuals with dialysis headache had worse quality of life in the domains of pain and general state of health (56.9 versus 76.4, p=0.01; 49.7 versus 60.2, p=0.03, respectively). Dialysis headache was associated with significantly greater impact on life (OR=24.4; 95%CI 2.6-226.6; logistic regression). The pulsatility index (transcranial Doppler ultrasonography) was lower among patients with dialysis headache than among those without them. Conclusions: Dialysis headaches occur frequently and are associated with worse quality of life and patterns of cerebral vasodilatation.
RESUMO
Antecedentes: A cefaleia é um dos sintomas mais frequentes que ocorrem durante as sessões de hemodiálise. Apesar da alta prevalência, essa cefaleia é pouco estudada. Objetivo: Avaliar as características, impacto e fatores associados à cefaleia da diálise. O comportamento da vasculatura cerebral também foi comparado entre pacientes com e sem cefaleia da diálise. Métodos: Este foi um estudo transversal. Pacientes consecutivos submetidos à hemodiálise foram avaliados por meio de questionário semiestruturado, do Headache Impact Test (HIT-6), Hospital Anxiety and Depression Scale e Short Form-36 Health Survey (SF-36). Foi realizada ultrassonografia Doppler transcraniana na primeira e na quarta horas de hemodiálise. Resultados: Foram incluídos 100 pacientes, 49 deles tinham cefaleia da diálise. Mulheres (OR=5,04; IC95% 1,95-13,04), indivíduos mais jovens (OR=1,05; IC95% 1,01-1,08), com maior escolaridade (OR=3,86; IC95% 1,4-10,7) e que passaram mais tempo em programas de diálise (OR=0,99, IC95% 0,98-1) tiveram mais cefaleia da diálise (regressão logística). Indivíduos com cefaleia dialítica tiveram pior qualidade de vida nos domínios dor e estado geral de saúde (56,9 versus 76,4, p=0,01; 49,7 versus 60,2, p=0,03, respectivamente). A cefaleia da diálise foi associada a um impacto significativamente maior na vida (OR=24,4; IC95% 2,6-226,6; regressão logística). O índice de pulsatilidade (ultrassonografia Doppler transcraniana) foi menor entre os pacientes com cefaleia da diálise do que entre aqueles sem. Conclusões: A cefaleia da diálise ocorre com frequência e está associada a pior qualidade de vida e a padrões de vasodilatação cerebral.
Keywords:
Headache - Pain - Renal Dialysis - Anxiety - Quality of Life - Ultrasonography, Doppler, TranscranialPalavras-chave:
Cefaleia - Dor - Diálise Renal - Ansiedade - Qualidade de Vida - Ultrassonografia Doppler TranscranianaAuthors’ contributions:
ESM, PASRF: conception and design; ESM, FCA, LMV: acquisition of data; ESM, RPP, PASRF: analysis and interpretation of data; ESM, RPP, FCA, LMV, PASRF: drafting the article and revising it critically for important intellectual content, and final approval of the version to be published.
Support
This study was financed in part by the Coordenação de Aperfeiçoamento de Pessoal de Nível Superior - Brasil (CAPES) - Finance Code 001.
Publikationsverlauf
Eingereicht: 02. April 2021
Angenommen: 14. Juni 2021
Artikel online veröffentlicht:
30. Januar 2023
© 2022. Academia Brasileira de Neurologia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)
Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil
-
References
- 1 Sousa Melo E, Carrilho Aguiar F, Sampaio Rocha-Filho PA. Dialysis headache: a narrative review. Headache 2017; Jan; 57 (01) 161-164 https://doi.org/10.1111/head.12875
- 2 Göksan B, Karaali-Savrun F, Ertan S, Savrun M. Haemodialysis-related headache. Cephalalgia 2004; Apr; 24 (04) 284-287 https://doi.org/10.1111/j.1468-2982.2004.00668.x
- 3 Goksel BK, Torun D, Karaca S, Karatas M, Tan M, Sezgin N. et al. Is low blood magnesium level associated with hemodialysis headache?. Headache 2006; Jan; 46 (01) 40-45 https://doi.org/10.1111/j.1526-4610.2006.00295.x
- 4 Antoniazzi AL, Bigal ME, Bordini CA, Speciali JG. Headache associated with dialysis: the International Headache Society criteria revisited. Cephalalgia 2003; Mar; 23 (02) 146-149 https://doi.org/10.1046/j.1468-2982.2003.00510.x
- 5 Bana DS, Yap AU, Graham JR. Headache during hemodialysis. Headache 1972; Apr; 12 (01) 1-14 https://doi.org/10.1111/j.1526-4610.1972.hed1201001.x
- 6 Gozubatik-Celik G, Uluduz D, Goksan B, Akkaya N, Sohtaoglu M, Uygunoglu U. et al. Hemodialysis-related headache and how to prevent it. Eur J Neurol 2019; Jan; 26 (01) 100-105 https://doi.org/10.1111/ene.13777
- 7 Alessandri M, Massanti L, Geppetti P, Bellucci G, Cipriani M, Fanciullacci M. Plasma changes of calcitonin gene-related peptide and substance P in patients with dialysis headache. Cephalalgia 2006; Nov; 26 (11) 1287-1293 https://doi.org/10.1111/j.1468-2982.2006.01217.x
- 8 Zepeda-Orozco D, Quigley R. Dialysis disequilibrium syndrome. Pediatr Nephrol 2012; Dec; 27 (12) 2205-2211 https://doi.org/10.1007/s00467-012-2199-4
- 9 Headache Classification Committee of the International, Society. International classification of headache disorders, 3rd edition (beta version). Cephalalgia 2013; Jul; 33 (09) 629-808 https://doi.org/10.1177/0333102413485658
- 10 Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; Jan; 38 (01) 1-211 https://doi.org/10.1177/0333102417738202
- 11 Freedman ND, Park Y, Abnet CC, Hollenbeck AR, Sinha R. Association of coffee drinking with total and cause-specific mortality. N Engl J Med 2012; May; 366 (20) 1891-1904 https://doi.org/10.1056/NEJMoa1112010
- 12 Martin M, Blaisdell B, Kwong JW, Bjorner JB. The Short-Form Headache Impact Test (HIT-6) was psychometrically equivalent in nine languages. J Clin Epidemiol 2004; Dec; 57 (12) 1271-1278 https://doi.org/10.1016/j.jclinepi.2004.05.004
- 13 Gandek B, Alacoque J, Uzun V, Andrew-Hobbs M, Davis K. Translating the Short-Form Headache Impact Test (HIT-6) in 27 countries: methodological and conceptual issues. Qual Life Res 2003; Dec; 12: 975-979 https://doi.org/10.1023/A:1026171315263
- 14 Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; Jun; 67 (06) 361-370 https://doi.org/10.1111/j.1600-0447.1983.tb09716.x
- 15 Botega N, Bio M, Zomignani M, Garcia J C, Pereira W. Mood disorders among medical in-patients: a validation study of the hospital anxiety and depression scale (HAD). Rev Saúde Pública 1995; Oct; 29 (05) 355-363 https://doi.org/10.1590/S0034-89101995000500004
- 16 Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. J Psychosom Res 2002; Feb; 52 (02) 69-77 https://doi.org/10.1016/s0022-3999(01)00296-3
- 17 Ciconelli RM, Ferraz MB, Santos W, Meinao I, Quaresma MR. Brazilian-Portuguese version of the SF-36. A reliable and valid quality of life outcome measure. Rev Bras Reum 1999; 39 (03) 143-150
- 18 De Jesus ACF, Oliveira HA, Paixão MOR, Fraga TP, Barreto FJN, Valença MM. Clinical description of hemodialysis headache in end-stage renal disease patients. Arq Neuro-Psiquiatr 2009; Dec; 67 (04) 978-981 https://doi.org/10.1590/S0004-282X2009000600003
- 19 Antoniazzi AL, Bigal ME. Expert opinion: Headaches and hemodialysis. Headache 2009; Mar; 49 (03) 463-466 https://doi.org/10.1111/j.1526-4610.2009.01359.x
- 20 Antoniazzi AL, Bigal ME, Bordini CA, Speciali JG. Headache and hemodialysis: evaluation of the possible triggering factors and of the treatment. Arq Neuro-Psiquiatr 2002; Sep; 60(3-A) 614-618
- 21 Stovner LJ, Hagen K, Jensen R, Katsarava Z, Rb Lipton, Ai Scher. et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; Mar; 27 (03) 193-210 https://doi.org/10.1111/j.1468-2982.2007.01288.x
- 22 Roberti J, Cummings A, Myall M, Harvey J, Lippiett K, Hunt K. et al. Work of being an adult patient with chronic kidney disease: a systematic review of qualitative studies. BMJ Open 2018; Sep; 8 (09) e023507 https://doi.org/10.1136/bmjopen-2018-023507
- 23 Hargreaves R, Olesen J. Calcitonin gene-related peptide modulators - the history and renaissance of a new migraine drug class. Headache 2019; Jun; 59 (06) 951-970 https://doi.org/10.1111/head.13510
- 24 Edvinsson L, Haanes KA, Warfvinge K, DiN Krause. CGRP as the target of new migraine therapies - successful translation from bench to clinic. Nat Rev Neurol 2018; Jun; 14 (06) 338-350 https://doi.org/10.1038/s41582-018-0003-1
- 25 Castro P, Azevedo E, Rocha I, Sorond F, Serrador JM. Chronic kidney disease and poor outcomes in ischemic stroke: is impaired cerebral autoregulation the missing link?. BMC Neurol 2018; Mar; 18 (01) 21-21 https://doi.org/10.1186/s12883-018-1025-4
- 26 Hata R, Matsumoto M, Handa N, Terakawa H, Sugitani Y, Kamacta T. Effects of hemodialysis on cerebral circulation evaluated by transcranial doppler ultrasonography. Stroke 1994; Feb; 25 (02) 408-412 https://doi.org/10.1161/01.str.25.2.408